ANRO (Alto Neuroscience) Total Operating Expense: $77.83 Mil (TTM As of Mar. 2026)


ANRO Alto Neuroscience Inc ANRO
12 GF Score
Price $28.07
! 2 Warning Signs
View Full Analysis

What is Alto Neuroscience Total Operating Expense?

Alto Neuroscience ANRO +3.81% 12 Total Operating Expense is $77.83 Mil as of Mar. 2026. GuruFocus rates ANRO with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Alto Neuroscience's Total Operating Expense for the three months ended in Mar. 2026 was $27.14 Mil. Alto Neuroscience's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $77.83 Mil.

Alto Neuroscience Total Operating Expense Related Terms

Alto Neuroscience Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Alto Neuroscience's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Total Operating Expense Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
9.29 27.46 37.81 68.61 66.36

Alto Neuroscience Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.68 18.68 14.95 17.06 27.14
ANRO
12GF Score
Alto Neuroscience Inc ANRO
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alto Neuroscience Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $77.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $77.83 Mil mean?
Alto Neuroscience (ANRO) has a Total Operating Expense of $77.83 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Alto Neuroscience and its competitors.
Is Alto Neuroscience's Total Operating Expense too high?
Alto Neuroscience's current Total Operating Expense is $77.83 Mil. Overall, Alto Neuroscience has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Alto Neuroscience's Total Operating Expense compare to SANA and AVTX?
Alto Neuroscience's Total Operating Expense of $77.83 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Alto Neuroscience and its competitors. Alto Neuroscience's current Total Operating Expense is $77.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alto Neuroscience stock overvalued right now?
Alto Neuroscience (ANRO) has a current Total Operating Expense of $77.83 Mil. The current Total Operating Expense is $77.83 Mil. Alto Neuroscience's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Alto Neuroscience (ANRO), the current Total Operating Expense is $77.83 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alto Neuroscience Business Description

Address 650 Castro Street, Suite 450, Mountain View, CA, USA, 94041
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
12GF Score

Get the complete analysis for ANRO

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.07
Price